Benzinga's Top Upgrades

Analysts at Canaccord Genuity upgraded Transition Therapeutics

from “hold” to “speculative buy.” The target price for Transition Therapeutics has been raised from $4.75 to $9.80. Transition Therapeutics' shares closed at $5.55 yesterday. Citigroup upgraded Blackhawk Network Holdings

from “neutral” to “buy.” The target price for Blackhawk Network Holdings has been raised from $25 to $27. Blackhawk Network's shares closed at $22.40 yesterday. Analysts at RBC Capital upgraded Johnson Controls

from “outperform” to “top pick.” The target price for Johnson Controls is set to $61. Johnson Controls' shares closed at $50.91 yesterday. Needham upgraded Geron

from “hold” to “buy.” The target price for Geron is set to $10. Geron's shares closed at $5.52 yesterday.